Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARDTNASDAQ:GHNASDAQ:OPCHNASDAQ:RDNT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health Partners$14.98-1.0%$13.20$11.31▼$20.72$2.14BN/A417,276 shs172,880 shsGHGuardant Health$37.13-7.1%$43.74$20.14▼$52.92$4.60B1.492.17 million shs1.79 million shsOPCHOption Care Health$32.73-1.0%$33.09$21.39▼$35.53$5.36B0.761.85 million shs1.91 million shsRDNTRadNet$58.09-3.4%$52.26$45.00▼$93.65$4.36B1.46684,277 shs390,433 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health Partners+0.07%+3.85%+20.85%+3.84%+1,509,999,900.00%GHGuardant Health-0.67%-3.36%-11.12%-18.43%+61.36%OPCHOption Care Health-0.06%+4.78%+3.07%+2.23%+13.80%RDNTRadNet-0.82%-0.61%+20.85%-6.45%+2.86%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARDTArdent Health Partners3.2578 of 5 stars3.50.00.00.02.70.03.1GHGuardant Health4.6983 of 5 stars4.52.00.04.34.12.50.6OPCHOption Care Health3.5213 of 5 stars1.45.00.04.22.72.50.6RDNTRadNet3.4165 of 5 stars2.71.00.04.63.22.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARDTArdent Health Partners 3.00Buy$20.6737.96% UpsideGHGuardant Health 3.05Buy$52.3240.90% UpsideOPCHOption Care Health 2.88Moderate Buy$35.508.46% UpsideRDNTRadNet 3.40Buy$69.7520.08% UpsideCurrent Analyst Ratings BreakdownLatest ARDT, OPCH, GH, and RDNT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/20/2025ARDTArdent Health PartnersStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$21.00 ➝ $21.005/15/2025ARDTArdent Health PartnersRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$21.00 ➝ $21.005/9/2025ARDTArdent Health PartnersGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$16.00 ➝ $18.005/6/2025GHGuardant HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$50.00 ➝ $60.005/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform5/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$52.00 ➝ $57.005/1/2025GHGuardant HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$60.00 ➝ $65.005/1/2025GHGuardant HealthTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$56.00 ➝ $60.005/1/2025GHGuardant HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$55.00 ➝ $60.005/1/2025GHGuardant HealthStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$53.00 ➝ $60.005/1/2025GHGuardant HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$65.00 ➝ $70.00(Data available from 5/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARDTArdent Health Partners$6.02B0.36N/AN/AN/A∞GHGuardant Health$774.00M5.94N/AN/A$1.34 per share27.71OPCHOption Care Health$5.19B1.03$1.90 per share17.19$8.03 per share4.08RDNTRadNet$1.87B2.33$3.09 per share18.81$11.79 per share4.93Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARDTArdent Health Partners$53.90M$1.639.197.64N/AN/AN/AN/AN/AGHGuardant Health-$479.45M-$3.39N/AN/AN/A-59.05%-19,157.20%-25.96%8/6/2025 (Estimated)OPCHOption Care Health$267.09M$1.2427.5025.982.304.37%15.30%6.57%7/30/2025 (Estimated)RDNTRadNet$3.04M-$0.43N/A109.60N/A-0.25%4.29%1.45%8/5/2025 (Estimated)Latest ARDT, OPCH, GH, and RDNT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025ARDTArdent Health Partners$0.21$0.29+$0.08$0.29$1.50 billion$1.50 billion4/30/2025Q1 2025GHGuardant Health-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million4/29/2025Q1 2025OPCHOption Care Health$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billion2/27/2025Q4 2024RDNTRadNet$0.21$0.22+$0.01$0.07$459.42 million$477.10 million2/26/2025Q4 2024ARDTArdent Health Partners$0.50$0.81+$0.31$0.81$1.48 billion$1.61 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARDTArdent Health PartnersN/AN/AN/AN/AN/AGHGuardant HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARDTArdent Health Partners0.781.911.78GHGuardant HealthN/A6.225.85OPCHOption Care Health0.771.731.32RDNTRadNet0.892.162.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARDTArdent Health PartnersN/AGHGuardant Health92.60%OPCHOption Care Health98.05%RDNTRadNet77.90%Insider OwnershipCompanyInsider OwnershipARDTArdent Health Partners1.70%GHGuardant Health6.10%OPCHOption Care Health0.64%RDNTRadNet5.12%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARDTArdent Health Partners24,200143.04 millionN/AOptionableGHGuardant Health1,790123.89 million116.76 millionNot OptionableOPCHOption Care Health5,600163.75 million169.09 millionOptionableRDNTRadNet8,97075.03 million70.24 millionOptionableARDT, OPCH, GH, and RDNT HeadlinesRecent News About These Companies4,892 Shares in RadNet, Inc. (NASDAQ:RDNT) Purchased by Sherbrooke Park Advisers LLCMay 21 at 5:49 AM | marketbeat.comRadNet, Inc. (NASDAQ:RDNT) Shares Purchased by Tidal Investments LLCMay 20 at 7:40 AM | marketbeat.comRadNet, Inc. (NASDAQ:RDNT) Position Boosted by RTW Investments LPMay 18 at 6:54 AM | marketbeat.comAmeriprise Financial Inc. Sells 22,778 Shares of RadNet, Inc. (NASDAQ:RDNT)May 18 at 3:30 AM | marketbeat.comLMR Partners LLP Sells 18,203 Shares of RadNet, Inc. (NASDAQ:RDNT)May 17, 2025 | marketbeat.comRadNet, Inc. (NASDAQ:RDNT) COO Sells $174,660.00 in StockMay 16, 2025 | insidertrades.comRadNet, Inc. (NASDAQ:RDNT) Shares Bought by Deutsche Bank AGMay 16, 2025 | marketbeat.comHere's What Analysts Are Forecasting For RadNet, Inc. (NASDAQ:RDNT) After Its First-Quarter ResultsMay 16, 2025 | finance.yahoo.comRadNet (NASDAQ:RDNT) Upgraded at StockNews.comMay 15, 2025 | marketbeat.comStockNews.com Upgrades RadNet (NASDAQ:RDNT) to "Sell"May 14, 2025 | americanbankingnews.comRadNet, Inc. Reports Q1 2025 Financial Results with Revenue Growth Despite Weather Challenges and Plans for iCAD AcquisitionMay 13, 2025 | nasdaq.comRadNet Inc (RDNT) Q1 2025 Earnings Call Highlights: Navigating Challenges and Seizing Growth ...May 13, 2025 | finance.yahoo.comRadNet's Resilient Recovery: Strong Growth Trends and Adjusted GuidanceMay 12, 2025 | news.themarketisopen.comRadNet, Inc. (RDNT) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.com25,503 Shares in RadNet, Inc. (NASDAQ:RDNT) Bought by Fred Alger Management LLCMay 12, 2025 | marketbeat.comDZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Reduces Position in RadNet, Inc. (NASDAQ:RDNT)May 12, 2025 | marketbeat.comCentiva Capital LP Purchases Shares of 8,277 RadNet, Inc. (NASDAQ:RDNT)May 12, 2025 | marketbeat.comRadNet Reports First Quarter Financial Results and Revises Upwards 2025 Financial Guidance Ranges for Revenue and Adjusted EBITDA¹May 11, 2025 | globenewswire.comNotable Friday Option Activity: HOOD, RKLB, RDNTMay 11, 2025 | nasdaq.comRadNet Stock Short Interest Report | NASDAQ:RDNT | BenzingaMay 11, 2025 | benzinga.comEarnings To Watch: RadNet (RDNT) Reports Q1 Results TomorrowMay 11, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?NVIDIA Stock Surges on Bullish News: How High Could It Climb?By Thomas Hughes | May 13, 2025View NVIDIA Stock Surges on Bullish News: How High Could It Climb?Palantir’s Latest Deal Could Put a Freeze on Its Stock PriceBy Chris Markoch | May 12, 2025View Palantir’s Latest Deal Could Put a Freeze on Its Stock PriceWhy Amazon May Never Dip Below $200 AgainBy Sam Quirke | May 13, 2025View Why Amazon May Never Dip Below $200 AgainJoby Aviation Shares Eye Breakout After Transition Flight WinBy Jeffrey Neal Johnson | April 30, 2025View Joby Aviation Shares Eye Breakout After Transition Flight WinARDT, OPCH, GH, and RDNT Company DescriptionsArdent Health Partners NYSE:ARDT$14.98 -0.15 (-0.99%) Closing price 03:59 PM EasternExtended Trading$14.94 -0.04 (-0.30%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Guardant Health NASDAQ:GH$37.13 -2.84 (-7.10%) Closing price 03:59 PM EasternExtended Trading$37.35 +0.22 (+0.60%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Option Care Health NASDAQ:OPCH$32.73 -0.34 (-1.03%) Closing price 03:59 PM EasternExtended Trading$32.71 -0.02 (-0.06%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.RadNet NASDAQ:RDNT$58.09 -2.07 (-3.44%) Closing price 03:59 PM EasternExtended Trading$58.08 -0.01 (-0.01%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Could Rally as EU Antitrust Case Nears Resolution Canada Goose Soars 30%—Is This Rally Built to Last? Palo Alto Networks: Buy The Dip, Long-Term Tailwinds Ahead Lowe’s Stock Uptrend Can Continue for These 2 Reasons CrowdStrike Near Breakout: Is Now the Time to Buy? Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era Rivian Stock Below $20: Charging Up or in the Breakdown Lane? 3 Reasons Salesforce Could Be Back at All-Time Highs by June Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
